MediPharm Labs Corp. (TSE:LABS – Get Free Report)’s stock price was down 12.5% during mid-day trading on Friday . The stock traded as low as C$0.07 and last traded at C$0.07. Approximately 27,310 shares were traded during mid-day trading, a decline of 93% from the average daily volume of 378,419 shares. The stock had previously closed at C$0.08.
MediPharm Labs Stock Performance
The company has a debt-to-equity ratio of 1.45, a current ratio of 3.21 and a quick ratio of 3.10. The company has a market capitalization of C$31.12 million, a price-to-earnings ratio of -2.58 and a beta of 0.88. The stock has a 50-day moving average price of C$0.07 and a 200-day moving average price of C$0.07.
MediPharm Labs Company Profile
MediPharm Labs Corp., a pharmaceutical company, produces and sells pharmaceutical-quality cannabis oil and concentrates, and advanced derivative products in Canada and internationally. The company formulates, processes, packages, and distributes cannabis extracts and advanced cannabinoid-based products.
Recommended Stories
- Five stocks we like better than MediPharm Labs
- What Are Dividend Contenders? Investing in Dividend Contenders
- Analysts Lift Archer Aviation Stock Despite Earnings Miss
- What is a Bond Market Holiday? How to Invest and Trade
- 5 Best Gold ETFs for March to Curb Recession Fears
- What Are Dividend Achievers? An Introduction
- 3 Stocks for Your Watchlist: Unlocking Tomorrow’s Winners Today
Receive News & Ratings for MediPharm Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MediPharm Labs and related companies with MarketBeat.com's FREE daily email newsletter.
